ABOUT US
ELRIG is a not-for-profit organisation serving the life science & drug discovery communities.
Posters
Find posters at Research & Innovation
| Poster No | First Name | Last Name | Organization | Title |
| 1 | Charlotte R | Bell | Sygnature Discovery | Characterising the response of tumours to fractionated radiotherapy and immune checkpoint inhibitors |
| 2 | Matthew | Broadsmith | Stream Bio | Conjugated Polymer Nanoparticles: exceptionally fluorescent and highly sensitive molecular bioimaging probes for fluorescent imaging and flow cytometry |
| 3 | Hannah | Peace | Stream Bio | Novel lateral flow technology detecting infection earlier: Conjugated Polymer Nanoparticles |
| 4 | Joel | Cresser-Brown | Bio-techne | Validating Targets for TPD using dTAG – a comprehensive workflow solution |
| 5 | Veronique | De Conto | HCS Pharma | Influence of the extracellular matrix in breast cancer metastasis development |
| 6 | Aya | Emam | University Of Manchester | In silico design of small molecule probes of fibrosis using molecular dynamics simulations |
| 7 | Ashley | Fowler | The Francis Crick Institute | Thinking beyond the benchtop instrument: use of integrated automation to enhance laboratory workflows |
| 8 | Amy | George | Newcastle University | Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling |
| 9 | Anusha | Gupta | Newcells Biotech Ltd. | Modelling epithelial barrier function and mucocilary clearance using small airway epithelium cells |
| 10 | Jamie | Jordan | Newcells | An in vitro Proximal tubule cell model that predicts Antibiotic Renal Toxicity |
| 11 | Christopher | King | Fusion Antibodies Plc | AI/ML-Ab™ (Aim-Lab) AI Assisted De-Novo Design and Discovery |
| 12 | Emma | Lee | King's College London | The pharmacological properties and prospective clinical applications of Salix alba bark: a literature review |
| 13 | Leonie | Mueller | Newcastle University | Development of a MALDI-TOF-MS HT capable screening assay for iPSC macrophage phenotyping and drug compound characterization |
| 14 | Kirsten | Ramsay | Newcells Biotech | A high throughput, in vitro assessment of antibiotic induced Podocyte Injury |
| 15 | Emily | Sampey | University Of Manchester | Design and synthesis of new classes of phosphatase inhibitor using novel computational methods. |
| 16 | Tove | Selvin | Uppsala University | The Immuno-Oncology Hollow Fiber Assay: Closing the gap between in vitro assays and complex mouse models |
| 17 | Ryan | Waite | Durham University | Novel anti-microbial small molecule photosensitiser to treat resistant gram-positive bacterial infections |
| 18 | Luke | Alderwick | Charles River Laboratories | Azetidines kill multidrug resistant Mycobacterium tuberculosis without detectable resistance by blocking mycolate assembly |
| 19 | Hasan | Alkassem | Biosynth | Unlocking Possibilities in Nucleoside Chemistry |
| 20 | Roger | Bosse | BioSignal2 Inc. | EnLIGHT OMEGA: a novel and improved Luminescent Oxygen Channeling based assay platform |
| 21 | Alex | Corbett | University Of Exeter | High throughput imaging using the Exeter Multiscope |
| 22 | Sabrina | De Munnik | Charles River Laboratories | Supporting CAR-T cell therapy development from concept to cure |
| 23 | Kathrin | Grundner-Culemann | Omicscouts | Cell-based Reactive Cysteine Profiling of an Electrophile Fragment Library to Explore Novel Target Opportunities |
| 24 | Charlotte | Hind | UKHSA | Open Innovation in early-stage Antimicrobial Drug Discovery |
| 25 | David | Jones | Selvita | Proteins & Structures: High-quality recombinant proteins and structural biology services |
| 26 | Theoni (Tania) | Katopodi | Sygnature Discovery | The implantation site impacts the tumour growth kinetics and tumour immune infiltrate in EO771 and 4T1 syngeneic breast cancer models |
| 27 | Julio | Martin | A4cell | Real-time monitoring of intracellular changes in 3D biology resembling relevant physiological processes in drug discovery |
| 28 | Sophie | Mayle | Bio-rad Abd Serotec | Bio-Rad can Offer Faster Generation of Anti-Drug Antibodies Using SpyTag Technology |
| 29 | Nicola | McCarthy | Milner Therapeutics Institute | The AZ-MRC-MTI Functional Genomics Screening Laboratory |
| 30 | Manal | Mohammed | University of Westminster | Developing Phage Therapy by Investigating the Basis of Bacteria-Phage interaction |
| 31 | Elizabeth | Mouchet | Astrazeneca | Mechanistic Prediction of Genotoxicity using Cell Painting |
| 32 | Ilaria | Proietti Silvestri | Lcc Liverpool Chirochem | 3Discovery platform: boosting hit-identification and lead-optimisation efficiency by merging fragment screening, virtual screening, parallel synthesis and chirally pure chemical space to identify leads for PIM1 Kinase |
| 33 | Johannes | Reynisson | Keele University | Phosphatidylcholine-specific phospholipase C as a promising drug target |
| 34 | Niklas | Rieck | acCELLerate | Free-to-use Cryostock Management Software |
| 35 | Stephanie | Sandiford | Evotec | Application of the hollow fibre infection model (HFIM) as an alternative to in vivo infectious disease models to assess efficacy of aztreonam-avibactam (AZT/AVI) against a metallo-β-lactamase producing strain of Escherichia coli |
| 36 | John | Vincent | Medicines Discovery Catapult | MDC Chemical Protein Stability Assay (CPSA) A Novel Target Engagement Approach |
| 37 | Kirsty | Winn | Selvita | Tackling antimicrobial resistance: In vitro discovery services |
| 38 | Andy | Wise | Evotec | Development of relevant in vitro and in vivo biofilm models for assessment of antimicrobials in development |
| 39 | Steven | Worrall | Upm Biomedicals | Automated 3D Cell-Based Assays in Animal-Free Nanofibrillar Cellulose Hydrogels for High-Throughput Screening |
| 40 | Andrew | Scott | Concept Life Sciences | Property-structure-function analysis of complex LNPs using integrative biophysical, molecular-, and cell-based assays |